Nanoform Finland Oyj (STO:NANOFS)

Market Cap	606.71M -46.9%
Revenue (ttm)	54.35M +37.1%
Net Income	-193.70M
EPS	-2.27
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	76,600
Average Volume	42,059
Open	7.17
Previous Close	7.06
Day's Range	7.17 - 7.42
52-Week Range	6.90 - 15.22
Beta	0.31
RSI	21.94
Earnings Date	Feb 26, 2026

About Nanoform Finland Oyj

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and flexible dosage forms of nanoformed drug substances. It also offers STARMAP,...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 173
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: NANOFS

Financial Performance

In 2025, Nanoform Finland Oyj's revenue was 5.02 million, an increase of 37.10% compared to the previous year's 3.66 million. Losses were -17.90 million, -23.60% less than in 2024.

Financial numbers in EUR